INDONESIA GETS MORNING-AFTER-PILLS AFTER ISLAMIC GROUP CONCEDES TO UN
JAKARTA, Dec 7, 2000 (LSN.ca) - The Inter Press Service reported Monday that a major Islamic religious group in Indonesia has conceded to the United Nations, the World Health Organization and others involved in an international promotion of the abortifacient morning-after-pill. The Muhammadiyah has agreed to stock its clinics with Postinor-2, the version of the abortifacient drugs the international consortium has been pushing in Asia. The religious group cited sections from the Koran, claiming the drugs did not offend the teachings of Islam. They have accepted the false argument that the drugs prevent pregnancy rather than cause abortion of an already created human being. Muhammadiyah is also organizing seminars promoting the drugs.
The news report notes that Muhammadiyah’s support was crucial in getting Postinor-2 registered with health authorities in Indonesia - a prime target for population controllers since it is the world’s fourth most populous nation. (IPS, HEALTH: Religious Backing Boosts Use of Contraception, Dec 4, 2000)
The Indonesian Muslims do not seem to be aware that co-operation with international de-population organizations, which are strongly anti-religious, will likely eventually lead to a critical, if not fatal weakening of their family supportive Muslim culture.
LifeSite first exposed the existence of the International Consortium on Emergency Contraception (ICEC) last year. It was reported that the rapid proliferation of abortifacient “emergency contraception” around the world in the past few years was engineered by an international group of abortion supporters. Formed in 1996, the ICEC includes UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (Geneva); International Planned Parenthood Federation (London); The Population Council (New York - which holds the rights to RU-486); The Concept Foundation (Bangkok); Pacific Institute for Women’s Health (Los Angeles); Pathfinder International (Boston); Population Services International (Washington, DC); and Program for Appropriate Technology in Health (PATH).
See LifeSite’s expose on the Consortium at http://lsn.ca/ldn/1999/dec/991210a.html